A targeted salvage therapy with brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients who received autologuos stem cell transplantation (ASCT).
Nurdan Taçyıldız(Ankara University), Esra Pekpak(Ankara University), Emel Ünal(Ankara University), Gülşah Tanyıldız(Ankara University), Handan Dinçaslan(Pediatric Oncology Group), Gülsan Yavuz
Cited by 1
Related Papers
Combined immunodeficiency and Epstein-Barr virus–induced B cell malignancy in humans with inherited CD70 deficiency
|The Journal of Experimental Medicine|2016|153
Successful treatment of central venous catheter infection due to <i>Candida lipolytica</i> by caspofungin‐lock therapy
|Mycoses|2011|35
Soy Isoflavones Ameliorate the Adverse Effects of Chemotherapy in Children
|Nutrition and Cancer|2010|30
Retinoblastoma in Turkey: Results From a Tertiary Care Center in Ankara
|Journal of Pediatric Ophthalmology & Strabismus|2013|25